Detailed price information for Coinbase Global Cl A (COIN-Q) from The Globe and Mail including charting and trades.
Azenta shares fall 7.4% after its fiscal Q4 call; revenue rises 5% to $167 million, while Multiomics organic sales decline 1%.
Its final earnings report for fiscal 2026 was impressive.
Azenta looks undervalued as recurring revenue tops 50% and cash nears 30% of market cap. Click for more on AZTA stock.
Detailed price information for Azenta Inc (AZTA-Q) from The Globe and Mail including charting and trades.
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the drug development inputs & services industry, including Azenta (NASDAQ:AZTA) and its peers.
Detailed price information for Azenta Inc (AZTA-Q) from The Globe and Mail including charting and trades.
Azenta (AZTA) said Friday it received full repayment, ahead of maturity, of a $35 million secured ve
Check out the companies making headlines yesterday:
Detailed price information for Azenta Inc (AZTA-Q) from The Globe and Mail including charting and trades.
Shares of life sciences company Azenta (NASDAQ:AZTA) fell 9.1% in the afternoon session after the company announced, in a regulatory filing, that President and CEO John Marotta resigned from his executive roles and board seat, with current director Dr. Martin Madaus appointed as interim President and CEO.
Azenta, Inc. (Nasdaq: AZTA) ("Azenta" or "the Company") today announced that current member of the Board of Directors (the "Board") Dr. Martin Madaus has been appointed interim President and CEO, and that John Marotta has resigned as an executive officer and director of the Company.
This is the newest page. Registered accounts read further back.